David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.83% |
| 2 | Healthcare | 10.76% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Financials | 8.43% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
PUT
PepsiCo
PEP
$197B
| $7.26M | 0.01% |
66,500
-15,000
| -18% | -$1.71M |
|
|
SAGE
1152
CALL
DELISTED
Sage Therapeutics
SAGE
| $7.25M | 0.01% |
45,000
+15,000
| +50% | +$2.55M |
|
1153
TAL Education Group
TAL
$6.37B
| $7.23M | 0.01% |
194,995
+109,655
| +128% | +$3.76M |
|
1154
CALL
Moody's
MCO
$88.6B
| $7.23M | 0.01% |
44,800
-1,800
| -4% | -$291K |
|
1155
PUT
Tractor Supply
TSCO
$18.7B
| $7.19M | 0.01% |
570,500
-193,000
| -25% | -$2.69M |
|
1156
Idexx Laboratories
IDXX
$44.1B
| $7.19M | 0.01% |
37,546
-5,683
| -13% | -$1.05M |
|
|
CS
1157
DELISTED
Credit Suisse Group
CS
| $7.17M | 0.01% |
427,295
-378,769
| -47% | -$6.94M |
|
|
HDP
1158
DELISTED
Hortonworks, Inc.
HDP
| $7.15M | 0.01% |
350,965
+238,279
| +211% | +$4.69M |
|
|
VRNT
1159
DELISTED
Verint Systems
VRNT
| $7.12M | 0.01% |
328,261
+99,931
| +44% | +$2.06M |
|
|
HIFR
1160
DELISTED
InfraREIT, Inc.
HIFR
| $7.12M | 0.01% |
366,600
-104,593
| -22% | -$1.99M |
|
|
PDLI
1161
DELISTED
PDL BioPharma, Inc.
PDLI
| $7.12M | 0.01% |
2,422,223
+406,870
| +20% | +$1.11M |
|
|
VSTO
1162
DELISTED
Vista Outdoor Inc.
VSTO
| $7.11M | 0.01% |
435,669
+48,239
| +12% | +$783K |
|
|
THS
1163
DELISTED
Treehouse Foods
THS
| $7.09M | 0.01% |
185,153
-179,748
| -49% | -$7.82M |
|
1164
State Street SPDR S&P Retail ETF
XRT
$329M
| $7.06M | 0.01% |
+159,300
| New | +$7.3M |
|
|
ELGX
1165
DELISTED
Endologix Inc
ELGX
| $7.03M | 0.01% |
166,299
+30,830
| +23% | +$1.32M |
|
1166
Hilton Worldwide
HLT
$74.3B
| $7.03M | 0.01% |
89,219
-56,550
| -39% | -$4.64M |
|
|
NUVA
1167
DELISTED
NuVasive, Inc.
NUVA
| $7.02M | 0.01% |
134,421
-2,214
| -2% | -$112K |
|
1168
CALL
Mettler-Toledo International
MTD
$28B
| $7.01M | 0.01% |
12,200
-12,400
| -50% | -$7.8M |
|
|
RPAI
1169
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $7.01M | 0.01% |
601,539
+76,678
| +15% | +$923K |
|
|
HZNP
1170
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7M | 0.01% |
493,085
+139,210
| +39% | +$2.06M |
|
|
MON
1171
PUT
DELISTED
Monsanto Co
MON
| $7M | 0.01% |
60,000
+5,500
| +10% | +$662K |
|
1172
CALL
J.M. Smucker
SJM
$13.5B
| $6.99M | 0.01% |
56,400
| – | – |
|
|
DBD
1173
DELISTED
Diebold Nixdorf Incorporated
DBD
| $6.99M | 0.01% |
454,079
+74,048
| +19% | +$1.24M |
|
1174
CALL
Kroger
KR
$36.2B
| $6.98M | 0.01% |
291,700
-338,200
| -54% | -$9.19M |
|
1175
Pilgrim's Pride
PPC
$7.57B
| $6.97M | 0.01% |
283,207
-695,653
| -71% | -$18.7M |
|
Similar funds
David Shaw's Q1 2018 Portfolio in Review
As of Q1 2018, David Shaw held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- David Shaw added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- David Shaw's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- David Shaw fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- David Shaw's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- David Shaw opened 451 new positions and closed 554 in Q1 2018.
- David Shaw's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.